The company in question is, Nevro Corp. (NYSE:NVRO) currently with a stock price of 98.36 (-0.71% today). The market cap for Nevro Corp. is 2881.95, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for Nevro Corp. is 104.13. Currently Nevro Corp. is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for Nevro Corp. is 480.58 and so far today it is 172197.
Performance in the last year for Nevro Corp. has been 131.91%. For EPS growth, Nevro Corp. has seen a growth of -104.60%, and is looking to grow in the next year to 51.40%. More long term stats show that EPS growth has been *TBA over the last five years and could be 30.00% for the next five years. Nevro Corp. has seen sales growth quarter over quarter at 386.00%, with EPS growth quarter over quarter at 59.90%. The 20-day simple moving average is 1.87%, with the 200-day simple moving average coming to 33.48%.
Since the IPO date for Nevro Corp. on the 11/06/2014, Nevro Corp. has seen performance year to date to be 46.75%. With Nevro Corp. trading at 98.36, the dividend yield is *TBA, and the EPS is -1.84.
So could Nevro Corp., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 19.79 and the P/B is at 11.41. The P/cash is 9.92, with P/free cash flow at *TBA.
Nevro Corp. ability to deal with debt shows that the current ratio is 13.2, and the quick ratio is 10.9. This is with long term debt/equity at 0.55, and total debt/equity at 0.55.
In terms of margins, Nevro Corp. has a gross margin of 63.40%, an operating margin of -32.30% and a profit margin of -35.50%.Payout ratio for Nevro Corp. is *TBA. Return on assets come to -16.30% with return on investment coming to -25.00%.
Insider ownership for Nevro Corp., is at 2.20% and institutional ownership comes to 53.80%. Outstanding shares are at 29.09. While shares float is 25.65. The float short is currently 22.02%, and short ratio is 11.75.